Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy

• Autors principals: Jae Hee Choi (Autor), Min Jung Geum (Autor), Ji Eun Kang (Autor), Nam Gi Park (Autor), Yun Kyoung Oh (Autor), Sandy Jeong Rhie (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2021-11-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Doxorubicin and cyclophosphamide (AC)-based chemotherapy has been a standard regimen for early-stage breast cancer (ESBC) with an intermediate risk (10-20%) of febrile neutropenia (FN). Secondary prophylaxis of granulocyte colony-stimulating factor (G-CSF) is considered in patients receiving AC-base...